CymitQuimica logo
Péptidos

Péptidos

Los péptidos son cadenas cortas de aminoácidos unidas por enlaces peptídicos, que desempeñan papeles importantes como moléculas biológicas en los procesos celulares. Funcionan como hormonas, neurotransmisores y moléculas de señalización, y se utilizan ampliamente en aplicaciones terapéuticas y diagnósticas. Los péptidos también son cruciales en la investigación para estudiar las interacciones de proteínas, actividades enzimáticas y vías de señalización celular. En CymitQuimica, ofrecemos una amplia selección de péptidos de alta calidad para apoyar sus necesidades de investigación y desarrollo en biotecnología y farmacéutica.

Subcategorías de "Péptidos"

Productos de "Péptidos"

Ordenar por

productos por página.Hay 31415 productos en esta categoría.
  • Ac-CQDERLPHYLRDED-NH2


    Peptide Ac-CQDERLPHYLRDED-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-CQDERLPHYLRDED-NH2 include the following: UV-sensitive photoreceptor protein OPN5 in humans and mice D Kojima , S Mori, M Torii, A Wada, R Morishita - PloS one, 2011 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0026388

    Ref: 3D-PP43420

    ne
    A consultar
  • Ac-DLIEEAASRPVDAVPEQVKAAGAY-NH2


    Peptide Ac-DLIEEAASRPVDAVPEQVKAAGAY-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-DLIEEAASRPVDAVPEQVKAAGAY-NH2 include the following: A calcium/cAMP signaling loop at the ORAI1 mouth drives channel inactivation to shape NFAT induction X Zhang , T Pathak , R Yoast, S Emrich, P Xin - Nature , 2019 - nature.comhttps://www.nature.com/articles/s41467-019-09593-0

    Ref: 3D-PP43477

    ne
    A consultar
  • H-MSSYAFFVQTCR-OH


    Peptide H-MSSYAFFVQTCR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-MSSYAFFVQTCR-OH include the following: Sample preparation strategies for antibody-free quantitative analysis of high mobility group box 1 protein I Kvivik , G Jonsson, R Omdal , C Brede - Pharmaceuticals, 2021 - mdpi.comhttps://www.mdpi.com/1424-8247/14/6/537 a-Synuclein¢ laments bind the transcriptional regulator HMGB-1 EK Lindersson, P Haca–jrup , WP Gai , D Locker, D Martin - hal.sciencehttps://hal.science/hal-00088420v1/file/Lindersson2004.pdf alpha-Synuclein filaments bind the transcriptional regulator HMGB-1 EK Lindersson, P Hojrup , WP Gai , D Locker - , 2004 - journals.lww.comhttps://journals.lww.com/neuroreport/fulltext/2004/12220/_alpha__Synuclein_filaments_bind_the.9.aspx Identity of nuclear high-mobility-group protein, HMG-1, and sulfoglucuronyl carbohydrate-binding protein, SBP-1, in brain DKH Chou, JE Evans - Journal of , 2001 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1046/j.1471-4159.2001.00209.x

    Ref: 3D-PP48099

    1mg
    258,00€
    10mg
    305,00€
    100mg
    506,00€
  • Urumin


    Urumin is a veridical host defence peptide against influenza A virus.The peptide specifically targets the evolutionarily conserved H1 hemagglutinin stalk region of H1-containing influenza A viruses.Urumin has been used against drug-resistant influenza A viruses that are resistant against oseltamivir, zanamivir and peramivir. While its mechanism of action is not fully understood, urumin seems to inhibit viral growth by physically destroying influenza A virions, and is able to protect naive mice from doses of influenza A infection as high as 2 times the LD50. Because of its specific targeting of the hemagglutinin stalk region of the influenza A virus, the mechanism of action of urumin is similar to that of antibodies induced in the body by universal influenza vaccines.
    Peso molecular:2,959.4 g/mol

    Ref: 3D-CRB1001196

    1mg
    265,00€
    500µg
    194,00€
  • Fmoc-Tyr-OH

    CAS:
    Fórmula:C24H21NO5
    Pureza:98%
    Forma y color:Solid
    Peso molecular:403.42724

    Ref: IN-DA00IHEL

    1g
    22,00€
    5g
    26,00€
    10g
    30,00€
    25g
    57,00€
  • H-TGISPLALIK-OH


    Peptide H-TGISPLALIK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-TGISPLALIK-OH include the following: ASMS 2017 WP 055 S Mukherjee , S Walunj , P Sutar, A Datar, A Moiyadi - shimadzu.co.krhttps://www.shimadzu.co.kr/sites/shimadzu.co.kr/files/pim/pim_document_file/technical/white_papers/11486/apo21766.pdf Absolute two-point quantification of proteins using dimethylated proteotypic peptides RC Bollineni , CJ Koehler, B Thiede - Analyst, 2018 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2018/an/c8an01081a Mass spectrometric discovery and selective reaction monitoring (SRM) of putative protein biomarker candidates in first trimester Trisomy 21 maternal serum MF Lopez, R Kuppusamy, DA Sarracino - Journal of proteome , 2011 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/pr100153j Evaluation of interspecimen trypsin digestion efficiency prior to multiple reaction monitoring-based absolute protein quantification with native protein calibrators I van den Broek, NPM Smit, FP Romijn - Journal of Proteome , 2013 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/pr400763d On-column trypsin digestion coupled with LC-MS/MS for quantification of apolipoproteins CA Toth, Z Kuklenyik, JI Jones, BA Parks - Journal of , 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1874391916304225 Apolipoprotein B is a novel marker for early tau pathology in Alzheimer's disease C Picard, N Nilsson, A Labonte, D Auld - Alzheimer's & , 2022 - Wiley Online Libraryhttps://alz-journals.onlinelibrary.wiley.com/doi/abs/10.1002/alz.12442 Development of a specific, quantitative multiplexed SRM assay for ApoA-1 and ApoB proteins. B Krastins, G Myers, T Rezai, M Ospina, S Edwards - static.thermoscientific.comhttps://static.thermoscientific.com/images/D00308~.pdf Development of a synthetic protein quality control (QC) standard for the assessment of sample proteolysis reproducibility B Krastins, A Prakash, S Peterman - ASMS Poster , 2010 - static.thermoscientific.comhttps://static.thermoscientific.com/images/D00281~.pdf

    Ref: 3D-PP45294

    1mg
    227,00€
    10mg
    267,00€
    100mg
    486,00€
  • KLHL1 Blocking Peptide


    A synthetic peptide for use as a blocking control in assays to test for specificity of KLHL1 antibody, catalog no. 70R-8353
    Pureza:Min. 95%

    Ref: 3D-33R-1429

    100µg
    Descatalogado
    Producto descatalogado
  • Boc-Gly-Arg-Arg-AMC acetate salt

    CAS:
    Boc-Gly-Arg-Arg-AMC acetate salt is a protease inhibitor that inhibits the activity of serine proteases. This protein is a potent and selective inhibitor of the NS3 protease from hepatitis C virus, which is responsible for the cleavage of polyproteins into mature proteins. Boc-Gly-Arg-Arg-AMC acetate salt has been shown to be effective in transfection experiments and polymerase chain reaction, as well as in inhibiting the activity of soybean trypsin and mammalian tissue proteases.
    Fórmula:C29H44N10O7•(C2H4O2)x
    Pureza:Min. 98 Area-%
    Forma y color:Powder
    Peso molecular:644.72 g/mol

    Ref: 3D-FB110553

    1mg
    317,00€
    2mg
    477,00€
    5mg
    742,00€
    10mg
    1.005,00€
    25mg
    1.326,00€
  • Pleiotrophin, human


    Human pleiotrophin is a peptide that belongs to the family of neuropeptides. It has been shown to bind to ion channels in the cell membrane and is believed to regulate their function. This protein also binds with high affinity to the receptor tyrosine kinase, which are important for many cellular functions including signal transduction and cell growth. Pleiotrophin has been used as a research tool for studying protein interactions and for understanding how ion channels work. It can be used to study the mechanisms of various diseases such as hypertension, asthma, and diabetes mellitus. Pleiotrophin has also been shown to have an inhibitory effect on cytokine production in human cells. This inhibition may be due to its ability to activate p38 mitogen-activated protein kinase (MAPK) and suppress the transcription factor nuclear factor-κB (NF-κB).
    Fórmula:C658H1079N197O198S12
    Pureza:Min. 95%
    Peso molecular:15,302.6 g/mol

    Ref: 3D-PTN-4335-V

    50µg
    1.110,00€
  • H-GRKKRRQRRR-OH


    Peptide H-GRKKRRQRRR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GRKKRRQRRR-OH include the following: Histidine-enriched multifunctional peptide vectors with enhanced cellular uptake and endosomal escape for gene delivery Z Meng, L Luan, Z Kang, S Feng, Q Meng - Journal of materials , 2017 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2016/tb/c6tb02862d Delivery of Macromolecules into Live Cells by Simple Co-incubation with a Peptide YJ Lee, A Erazo-Oliveras , JP Pellois - ChemBioChem, 2010 - Wiley Online Libraryhttps://chemistry-europe.onlinelibrary.wiley.com/doi/abs/10.1002/cbic.200900527 The structure and configuration changes of multifunctional peptide vectors enhance gene delivery efficiency S Yang, Z Meng, Z Kang, C Sun, T Wang, S Feng - RSC , 2018 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2018/ra/c8ra04101f Peptide-based nanoprobes for molecular imaging and disease diagnostics P Zhang , Y Cui, CF Anderson , C Zhang, Y Li - Chemical Society , 2018 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2018/cs/c7cs00793k Peptide amphiphiles with multifunctional fragments promoting cellular uptake and endosomal escape as efficient gene vectors L Luan, Q Meng, L Xu, Z Meng, H Yan - Journal of Materials , 2015 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2014/tb/c4tb01353k Permeation peptide conjugates for in vivo molecular imaging applications KE Bullok, ST Gammon , S Violini - Molecular , 2006 - journals.sagepub.comhttps://journals.sagepub.com/doi/abs/10.2310/7290.2006.00001 Cellular Uptake Behavior of Poly(D,L-lactide-co-glycolide) Nanoparticles Derivatized with HIV-1 Tat49-57 Peptide (Abbreviated Title: Tat-PLGA Nanoparticles) JY Park, YS Nam , JO Kim, SH Han - Journal of , 2004 - koreascience.krhttps://koreascience.kr/article/JAKO200403042581757.pdf Recent advances in peptide-based nanomaterials for targeting hypoxia J Wang, J Liu, Z Yang - Nanoscale Advances, 2021 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2021/na/d1na00637a Targeted Delivery of the HLA-B ∗27-Binding Peptide into the Endoplasmic Reticulum Suppresses the IL-23/IL-17 Axis of Immune Cells in Spondylarthritis HC Yu, KY Huang, MC Lu, HL Huang - Mediators of , 2017 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1155/2017/4016802 Designed peptide assemblies for efficient gene delivery H Ma, M Cao - Langmuir, 2022 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.langmuir.2c02197 Tat peptide-mediated cellular delivery: back to basics H Brooks, B Lebleu, E Vivacašs - Advanced drug delivery reviews, 2005 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0169409X04002741 Cell-penetrating peptides-uptake, toxicity, and applications G Tunnemann, MC Cardoso - Peptides: Methods and Results on , 2009 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=6K6UxKhyZlMC&oi=fnd&pg=PA329&dq=(%22H-GRKKRRQRRR-OH%22+OR+%22GRKKRRQRRR%22+OR+%22NH2-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-OH%22)+AND+peptide&ots=YZt2yakLgn&sig=IwkYjLUpo9IK2x-WHR96s82CtnQ Rational design and characterisation of a linear cell penetrating peptide for non-viral gene delivery EM McErlean , M Ziminska , CM McCrudden - Journal of controlled , 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365920306878

    Ref: 3D-PP45349

    1mg
    227,00€
    10mg
    267,00€
    100mg
    486,00€
  • H-SLFNTVATL-OH


    Peptide H-SLFNTVATL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SLFNTVATL-OH include the following: Structure and dynamics of MHC class-I bound peptides SP Patil - 2008 - search.proquest.comhttps://search.proquest.com/openview/219708e423941b6eacfec8c7dcee7844/1?pq-origsite=gscholar&cbl=18750 Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance S Tenzer , E Wee, A Burgevin, G Stewart-Jones - Nature , 2009 - nature.comhttps://www.nature.com/articles/ni.1728 Amino acid similarity accounts for T cell cross-reactivity and for"holes" in the T cell repertoire S Frankild, RJ De Boer , O Lund , M Nielsen , C Kesmir - PloS one, 2008 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001831 Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical siblings with PJR Goulder , AK Sewell , DG Lalloo , DA Price - The Journal of , 1997 - rupress.orghttps://rupress.org/jem/article-abstract/185/8/1423/7136 Impact of Gag Sequence Variability on Level, Phenotype, and Function of Anti-HIV Gag-Specific CD8+ Cytotoxic T Lymphocytes in Untreated Chronically HIV-Infected M Lopez, V Soriano , S Lozano, P Martinez - AIDS Research & , 2006 - liebertpub.comhttps://www.liebertpub.com/doi/abs/10.1089/aid.2006.22.884 Distinct recognition of non-clade B human immunodeficiency virus type 1 epitopes by cytotoxic T lymphocytes generated from donors infected in Africa L Dorrell, T Dong , GS Ogg , S Lister, S McAdam - Journal of , 1999 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.73.2.1708-1714.1999 T cell cross-reactivity and conformational changes during TCR engagement JK Lee, G Stewart-Jones, T Dong , K Harlos - The Journal of , 2004 - rupress.orghttps://rupress.org/jem/article-abstract/200/11/1455/54291 Degenerate T-cell recognition of peptides on MHC molecules creates large holes in the T-cell repertoire JJA Calis, RJ De Boer , C KeÃ…Åžmir - PLoS computational biology, 2012 - journals.plos.orghttps://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1002412 Properties of MHC class I presented peptides that enhance immunogenicity JJA Calis, M Maybeno, JA Greenbaum - PLoS computational , 2013 - journals.plos.orghttps://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1003266 Quantitating T cell cross-reactivity for unrelated peptide antigens J Ishizuka, K Grebe , E Shenderov , B Peters - The Journal of , 2009 - journals.aai.orghttps://journals.aai.org/jimmunol/article/183/7/4337/81760 Previously hidden dynamics at the TCR-peptide-MHC interface revealed J Fodor , BT Riley , NA Borg , AM Buckle - The Journal of Immunology, 2018 - journals.aai.orghttps://journals.aai.org/jimmunol/article/200/12/4134/106526 The contribution of major histocompatibility complex contacts to the affinity and kinetics of T cell receptor binding H Zhang, HS Lim, B Knapp , CM Deane , M Aleksic - Scientific reports, 2016 - nature.comhttps://www.nature.com/articles/srep35326 Incoming HIV virion-derived Gag Spacer Peptide 2 (p1) is a target of effective CD8+ T cell antiviral responses H Yang, A Llano, S Cedeno, A von Delft , A Corcuera - Cell Reports, 2021 - cell.comhttps://www.cell.com/cell-reports/pdf/S2211-1247(21)00437-X.pdf Sensitization of tumour cells to lysis by virus-specific CTL using antibody-targeted MHC class I/peptide complexes GS Ogg , PR Dunbar , V Cerundolo - British journal of , 2000 - nature.comhttps://www.nature.com/articles/6691042 Dual molecular mechanisms govern escape at immunodominant HLA A2-restricted HIV epitope DK Cole , A Fuller, G Dolton , E Zervoudi - Frontiers in , 2017 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2017.01503/full Conflicting selective forces affect T cell receptor contacts in an immunodominant human immunodeficiency virus epitope AKN Iversen, G Stewart-Jones, GH Learn - Nature , 2006 - nature.comhttps://www.nature.com/articles/ni1298 HIV type 1-specific inter-and intrasubtype cellular immune responses in HIV type 1-infected Ugandans A Rutebemberwa, B Auma, J Gilmour - AIDS research and , 2004 - liebertpub.comhttps://www.liebertpub.com/doi/abs/10.1089/0889222041524643

    Ref: 3D-PP46998

    1mg
    212,00€
    10mg
    247,00€
    100mg
    445,00€
  • Biotin-CRF (human, rat)


    Catalogue peptide; min. 95% purity
    Fórmula:C218H358N62O65S3
    Peso molecular:4,983.85 g/mol

    Ref: 3D-VAC-00116

    1mg
    554,00€
    5mg
    1.483,00€
    10mg
    2.408,00€
  • Fz7-21

    CAS:
    Fz7-21, a peptide antagonist of FZD7, inhibits Wnt/β-catenin signaling (IC50=50-100nM) in cells with WNT3A.
    Fórmula:C83H114N18O23S2
    Pureza:99.8%
    Forma y color:Solid
    Peso molecular:1796.03

    Ref: TM-TP1263

    1mg
    74,00€
    5mg
    170,00€
    10mg
    274,00€
    25mg
    467,00€
    50mg
    653,00€
    100mg
    924,00€
  • CCDC110 Blocking Peptide


    A synthetic peptide for use as a blocking control in assays to test for specificity of CCDC110 antibody, catalog no. 70R-9333
    Pureza:Min. 95%

    Ref: 3D-33R-4326

    100µg
    Descatalogado
    Producto descatalogado
  • SIVmac239 - 29


    Custom research peptide; min purity 95%. For different specs please use the Peptide Quote Tool
    Peso molecular:1,574.8 g/mol

    Ref: 3D-PP50332

    ne
    A consultar
  • PLAT Blocking Peptide


    A synthetic peptide for use as a blocking control in assays to test for specificity of PLAT antibody, catalog no. 70R-4058
    Pureza:Min. 95%

    Ref: 3D-33R-9356

    1u
    Descatalogado
    100µg
    Descatalogado
    Producto descatalogado
  • KIFAP3 Blocking Peptide


    A synthetic peptide for use as a blocking control in assays to test for specificity of KIFAP3 antibody, catalog no. 70R-3387
    Pureza:Min. 95%

    Ref: 3D-33R-9969

    100µg
    Descatalogado
    Producto descatalogado
  • Des-Arg9-Bradykinin

    CAS:
    Des-Arg9-bradykinin is a peptide that is a potent activator of the B2 receptor. It is a potent inhibitor of ion channels, including Ca2+, K+ and Na+ channels. Des-Arg9-bradykinin has been used as a research tool in cell biology, particularly to investigate the role of bradykinins in signal transduction pathways. This chemical is highly purified and can be obtained from Sigma-Aldrich with CAS No. 15958-92-6.
    Fórmula:C44H61N11O10
    Pureza:Min. 95%
    Peso molecular:904.02 g/mol

    Ref: 3D-PBK-4067-V

    500µg
    171,00€
  • GPT2 Blocking Peptide


    A synthetic peptide for use as a blocking control in assays to test for specificity of GPT2 antibody, catalog no. 70R-2968
    Pureza:Min. 95%

    Ref: 3D-33R-2475

    100µg
    Descatalogado
    Producto descatalogado
  • H-YMLDLQP^ET-OH


    Peptide H-YMLDLQP^ET-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-YMLDLQP^ET-OH include the following: A TCR mimic monoclonal antibody for the HPV-16 E7-epitope p11-19/HLA-A* 02: 01 complex T Dao, S Mun, T Korontsvit, AG Khan, MA Pohl, T White - Plos one, 2022 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0265534 Development of mass spectrometry methodology for direct identification of viral epitopes from MHC I molecules R Blatnik - 2017 - archiv.ub.uni-heidelberg.dehttps://archiv.ub.uni-heidelberg.de/volltextserver/19834/ Immunological evaluation of a novel HLA-A2 restricted phosphopeptide of tumor associated Antigen, TRAP1, on cancer therapy MH Lin, KY Shen, BS Liu, IH Chen, YP Sher , GC Tseng - Vaccine: X, 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S259013621930018X TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies M Ahmed, A Lopez-Albaitero, D Pankov, BH Santich - JCI insight, 2018 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916246/ ARTEMIS: a novel mass-spec platform for HLA-restricted self and disease-associated peptide discovery KAK Finton, MY Brusniak, LA Jones, C Lin - Frontiers in , 2021 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2021.658372/full Human Papillomavirus Type 16 E7 Peptide-Directed CD8+ T Cells from Patients with Cervical Cancer Are Cross-Reactive with the Coronavirus NS2 Protein K Nilges, H Höhn, H Pilch, C Neukirch - Journal of , 2003 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.77.9.5464-5474.2003 Katja Nilges, Hanni Höhn, Henryk Pilch, Claudia Neukirch K Freitag, PJ Talbot , MJ Maeurer - Citeseerhttps://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=42484c04bb79d75c8ec3ae0ecfa79514359c66da Quantitative approaches to computational vaccinology IA Doytchinova , DR Flower - Immunology and Cell Biology, 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1046/j.1440-1711.2002.01076.x New tetramer technology offers new aspects in the definition of appropriate HPV target epitopes for novel vaccine designs in cervical cancer patients H Pilch, M Schmidt , E Steiner, R Seufert - Geburtshilfe und , 2005 - thieme-connect.comhttps://www.thieme-connect.com/products/ejournals/html/10.1055/s-2005-837534 Definition of the HLA-A2 restricted peptides recognized by human CD8+ effector T cells by flow-assisted sorting of the CD8+ CD45RA+ CD28- T cell H Höhn, M Julch, H Pilch, C Kortsik - Clinical & , 2003 - academic.oup.comhttps://academic.oup.com/cei/article-abstract/131/1/102/6458801 Direct identification of an HPV-16 tumor antigen from cervical cancer biopsy specimens DB Keskin , B Reinhold , SY Lee, G Zhang - Frontiers in , 2011 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2011.00075/full

    Ref: 3D-PP47566

    ne
    A consultar